Skip to main content
Top
Published in: Respiratory Research 1/2016

Open Access 01-12-2016 | Research

Expression of toll-like receptors 2 and 4 in subjects with asthma by total serum IgE level

Authors: Astrid Crespo-Lessmann, Eder Mateus, Silvia Vidal, David Ramos-Barbón, Montserrat Torrejón, Jordi Giner, Lorena Soto, Cándido Juárez, Vicente Plaza

Published in: Respiratory Research | Issue 1/2016

Login to get access

Abstract

Background

Emerging data suggest that innate immunity may play a role in asthma, particularly the toll-like receptors (TLRs). Some studies pointed to an involvement of TLRs 2 and 4 in the pathogenesis of allergic asthma, and other studies related TLRs to IgE. However, there are not any studies that have comprehensively evaluated the expression of TLRs 2 and 4 in inflammatory cells, in peripheral blood and induced sputum specimens from asthmatic patients, according to their total serum IgE.

Methods

We studied 44 asthmatic patients (15 with high total serum IgE and 29 with normal total serum IgE). On a single visit, all patients underwent: induced sputum, pulmonary function tests, determination of exhaled nitric oxide fraction, venipuncture for blood analysis and skin prick allergy tests. The induced sputum cellularity was analyzed by flow cytometry, where expression of TLRs 2 and 4 was studied using fluorochrome-conjugated monoclonal antibodies.

Results

Asthmatic patients with high total serum IgE showed, a higher percentage of macrophages expressing TLR4 (42.99 % ± 22.49) versus asthmatic patients with normal total serum IgE (28.84 % ± 15.16) (P = 0.048). Furthermore, we observed a correlation (but weak) between the percentage of macrophages expressing TLR4 in induced sputum and the total serum IgE level (R = 0.314; P = 0.040).

Conclusion

Asthmatic subjects with high total serum IgE show increased macrophage expression of TLR4 in induced sputum. This outcome may result from a link between innate immunity and IgE-mediated, adaptive immune responses in asthma, and point to TLR4 as a potential therapeutic target.
Literature
1.
go back to reference Fahy JV. Reducing IgE levels as a strategy for the treatment of asthma. Clin Exp Allergy. 2000;30 Suppl 1:16–21.CrossRefPubMed Fahy JV. Reducing IgE levels as a strategy for the treatment of asthma. Clin Exp Allergy. 2000;30 Suppl 1:16–21.CrossRefPubMed
2.
go back to reference Słodka A, Brzezińska-Błaszczyk E. Bacteria and viruses modulate FcεRI-dependent mast cell activity. Postepy Hig Med Dosw (Online). 2013;67:164–73.CrossRef Słodka A, Brzezińska-Błaszczyk E. Bacteria and viruses modulate FcεRI-dependent mast cell activity. Postepy Hig Med Dosw (Online). 2013;67:164–73.CrossRef
3.
go back to reference Yu Y, Blokhuis BR, Garssen J, Redegeld FA. Non-IgE mediated mast cell activation. Eur J Pharmacol. 2015;15:30144–8. Yu Y, Blokhuis BR, Garssen J, Redegeld FA. Non-IgE mediated mast cell activation. Eur J Pharmacol. 2015;15:30144–8.
4.
go back to reference West CE, Rydén P, Lundin D, Engstrand L, Tulic MK, Prescott SL. Gut microbiome and innate immune response patterns in IgE-associated eczema. Clin Exp Allergy. 2015 May 5. doi:10.1111/cea.12566. West CE, Rydén P, Lundin D, Engstrand L, Tulic MK, Prescott SL. Gut microbiome and innate immune response patterns in IgE-associated eczema. Clin Exp Allergy. 2015 May 5. doi:10.​1111/​cea.​12566.
5.
go back to reference Suurmond J, Dorjée AL, Knol EF, Huizinga TW, Toes RE. Differential TLR-induced cytokine production by human mast cells is amplified by FcɛRI triggering. Clin Exp Allergy. 2015;45(4):788–96.CrossRefPubMed Suurmond J, Dorjée AL, Knol EF, Huizinga TW, Toes RE. Differential TLR-induced cytokine production by human mast cells is amplified by FcɛRI triggering. Clin Exp Allergy. 2015;45(4):788–96.CrossRefPubMed
6.
go back to reference Crespo-Lessmann A, Juárez-Rubio C, Plaza-Moral V. Role of toll-like receptors in respiratory diseases. Arch Bronconeumol. 2010;46(3):135–42.CrossRefPubMed Crespo-Lessmann A, Juárez-Rubio C, Plaza-Moral V. Role of toll-like receptors in respiratory diseases. Arch Bronconeumol. 2010;46(3):135–42.CrossRefPubMed
7.
go back to reference Xu D, Liu H, Komai-Koma M. Direct and indirect role of toll-like receptor in Tcell mediated immunity. Cell Mol Inmunol. 2004;1:239–46. Xu D, Liu H, Komai-Koma M. Direct and indirect role of toll-like receptor in Tcell mediated immunity. Cell Mol Inmunol. 2004;1:239–46.
8.
go back to reference Arancibia S, Beltran C, Aguirre I, Silva P, Peralta A, Malinarich F, et al. Toll-like receptor are key participants in innate immune responses. Biol Res. 2007;40:97–112.CrossRefPubMed Arancibia S, Beltran C, Aguirre I, Silva P, Peralta A, Malinarich F, et al. Toll-like receptor are key participants in innate immune responses. Biol Res. 2007;40:97–112.CrossRefPubMed
9.
go back to reference Redecke V, Haäcker H, Datta S, Fermin A, Pitha P, Broide D, et al. Cutting edge: activation of toll-like receptor 2 induces a Th2 immune respose and promote experimental asthma. J Immunol. 2004;172:2739–43.CrossRefPubMed Redecke V, Haäcker H, Datta S, Fermin A, Pitha P, Broide D, et al. Cutting edge: activation of toll-like receptor 2 induces a Th2 immune respose and promote experimental asthma. J Immunol. 2004;172:2739–43.CrossRefPubMed
10.
go back to reference Fritz JH, Girardon DE. How toll-like receptors and Nod-like receptors contribute to innate immunity in mammals. J Endotoxin Res. 2005;11:390–4.CrossRefPubMed Fritz JH, Girardon DE. How toll-like receptors and Nod-like receptors contribute to innate immunity in mammals. J Endotoxin Res. 2005;11:390–4.CrossRefPubMed
11.
go back to reference Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, et al. Lipopolysaccharide-enhanced, toll like receptor 4 dependent T helper cell type 2 responses to inhaled antigen. J Exp Med. 2001;196:1645–51.CrossRef Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, et al. Lipopolysaccharide-enhanced, toll like receptor 4 dependent T helper cell type 2 responses to inhaled antigen. J Exp Med. 2001;196:1645–51.CrossRef
12.
go back to reference Rodriguez D, Keller AC, Faquim-Mauro EL, de Macedo MS, Cunha FQ, et al. Bacterial lipopolysaccharide signaling through toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol. 2003;171(2):1001–8.CrossRefPubMed Rodriguez D, Keller AC, Faquim-Mauro EL, de Macedo MS, Cunha FQ, et al. Bacterial lipopolysaccharide signaling through toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol. 2003;171(2):1001–8.CrossRefPubMed
13.
go back to reference Kim YK, Oh SY, Jeon SG, Park HW, Lee SY, Chun EY, et al. Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J Immunol. 2007;178(8):5375–82.CrossRefPubMed Kim YK, Oh SY, Jeon SG, Park HW, Lee SY, Chun EY, et al. Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J Immunol. 2007;178(8):5375–82.CrossRefPubMed
14.
go back to reference Fehrenback K, Port F, Grachowy G, Kalis C, Bessler W, Galanos C, et al. Stimulation of mast cells via FcvarepsilonR1 and TLR2: the type of ligand determines the outcome. Mol Immunol. 2007;44(8):2087–94.CrossRef Fehrenback K, Port F, Grachowy G, Kalis C, Bessler W, Galanos C, et al. Stimulation of mast cells via FcvarepsilonR1 and TLR2: the type of ligand determines the outcome. Mol Immunol. 2007;44(8):2087–94.CrossRef
15.
go back to reference Taylor RC, Richmond P, Upham JW. Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. J Allergy Clin Immunol. 2006;117(5):1148–54.CrossRefPubMed Taylor RC, Richmond P, Upham JW. Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. J Allergy Clin Immunol. 2006;117(5):1148–54.CrossRefPubMed
17.
go back to reference Weiss ST. Eat dirt — the hygiene hypothesis and allergic diseases. N Engl J Med. 2002;347:930–1.CrossRefPubMed Weiss ST. Eat dirt — the hygiene hypothesis and allergic diseases. N Engl J Med. 2002;347:930–1.CrossRefPubMed
18.
go back to reference Chun E, Lee S, Lee S, Shim E, Cho S, Min K, et al. Toll-like receptor expression on peripheral blood mononuclear cells in asthmatics; implications for asthma management. J Clin Immunol. 2010;30:459–64.CrossRefPubMed Chun E, Lee S, Lee S, Shim E, Cho S, Min K, et al. Toll-like receptor expression on peripheral blood mononuclear cells in asthmatics; implications for asthma management. J Clin Immunol. 2010;30:459–64.CrossRefPubMed
19.
go back to reference Zhang X, Shan P, Jiang G, Cohn L, Lee P. Research article. Toll-like receptor 4 deficiency causes pulmonary emphysema. J Clin Invest. 2006;116:3050–9.CrossRefPubMedPubMedCentral Zhang X, Shan P, Jiang G, Cohn L, Lee P. Research article. Toll-like receptor 4 deficiency causes pulmonary emphysema. J Clin Invest. 2006;116:3050–9.CrossRefPubMedPubMedCentral
20.
go back to reference Pons J, Sauleda J, Regueiro V, Santos C, López M, Ferrer J, et al. Expression of toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease. Respir Res. 2006;7:64.CrossRefPubMedPubMedCentral Pons J, Sauleda J, Regueiro V, Santos C, López M, Ferrer J, et al. Expression of toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease. Respir Res. 2006;7:64.CrossRefPubMedPubMedCentral
21.
go back to reference Koller B, Kappler M, Latzin P, Gaggar A, Schreiner M, Takyar S, et al. TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2- mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. J Immunol. 2008;181:2753–63.CrossRefPubMed Koller B, Kappler M, Latzin P, Gaggar A, Schreiner M, Takyar S, et al. TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2- mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. J Immunol. 2008;181:2753–63.CrossRefPubMed
22.
go back to reference Greene C, Branagan P, McElvaney N. Toll-like receptors as therapeutic targets in cystic fibrosis. Expert Opin Ther Targets. 2008;12:1481–95.CrossRefPubMed Greene C, Branagan P, McElvaney N. Toll-like receptors as therapeutic targets in cystic fibrosis. Expert Opin Ther Targets. 2008;12:1481–95.CrossRefPubMed
23.
go back to reference Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax. 2007;62(3):211–8.CrossRefPubMedPubMedCentral Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax. 2007;62(3):211–8.CrossRefPubMedPubMedCentral
25.
go back to reference Johansson SGO, Yman L. In Vitro Assays for Immunoglobulin E. Clin Rev Allergy. 1988;6(2):93–139.PubMed Johansson SGO, Yman L. In Vitro Assays for Immunoglobulin E. Clin Rev Allergy. 1988;6(2):93–139.PubMed
26.
go back to reference Vega JM, Badia X, Badiola C, López-Viña A, Olaguíbel JM, Picado C, et al. Covalair Investigator Group. Validation of the Spanish versión of the Asthma Control Test (ACT). J Asthma. 2007;44:867–72.CrossRefPubMed Vega JM, Badia X, Badiola C, López-Viña A, Olaguíbel JM, Picado C, et al. Covalair Investigator Group. Validation of the Spanish versión of the Asthma Control Test (ACT). J Asthma. 2007;44:867–72.CrossRefPubMed
27.
go back to reference Pepys J. Skin testing. Br J Hosp Med. 1975;14:412–4. Pepys J. Skin testing. Br J Hosp Med. 1975;14:412–4.
28.
go back to reference Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J Suppl. 1993;16:5–40.CrossRefPubMed Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J Suppl. 1993;16:5–40.CrossRefPubMed
29.
go back to reference García-Río F, Calle M, Burgos F, Casan P, Del Campo F, Galdiz JB, et al. Spirometry. Arch Bronconeumol. 2013;49(9):388–401.CrossRefPubMed García-Río F, Calle M, Burgos F, Casan P, Del Campo F, Galdiz JB, et al. Spirometry. Arch Bronconeumol. 2013;49(9):388–401.CrossRefPubMed
30.
go back to reference American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med. 2005;171:912–30.CrossRef American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med. 2005;171:912–30.CrossRef
31.
go back to reference Fortuna AM, Feixas T, Casan P. Determinacion de oxido nitrico en aire espirado mediante un equipo portatil en población sana. Arch Bronconeumol. 2007;43(3):176–9.CrossRefPubMed Fortuna AM, Feixas T, Casan P. Determinacion de oxido nitrico en aire espirado mediante un equipo portatil en población sana. Arch Bronconeumol. 2007;43(3):176–9.CrossRefPubMed
32.
go back to reference Paggiaro PL et al. Sputum induction. Eur Respir J Suppl. 2002;37:3s–8s.PubMed Paggiaro PL et al. Sputum induction. Eur Respir J Suppl. 2002;37:3s–8s.PubMed
33.
go back to reference Vidal J, Bellido C, Granel A, Crespo V, Vidal S, Bellido J, Granel C, Crespo A, Plaza V, Juárez C. Flow cytometry analysis of leukocytes in induced sputum from asthmatic patients. Inmunobiology. 2012;217:692–7.CrossRef Vidal J, Bellido C, Granel A, Crespo V, Vidal S, Bellido J, Granel C, Crespo A, Plaza V, Juárez C. Flow cytometry analysis of leukocytes in induced sputum from asthmatic patients. Inmunobiology. 2012;217:692–7.CrossRef
34.
go back to reference Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med. 1996;154(2 Pt 1):308–17.CrossRefPubMed Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med. 1996;154(2 Pt 1):308–17.CrossRefPubMed
35.
go back to reference Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992;47(1):25–9.CrossRefPubMedPubMedCentral Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992;47(1):25–9.CrossRefPubMedPubMedCentral
36.
go back to reference Andonegui G, Bonder C, Green F, Mullaly S, Zbytnuik L, Raharjo E, et al. Endothelium-derived Toll-like receptor 4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J Clin Invest. 2003;111(7):1011–20.CrossRefPubMedPubMedCentral Andonegui G, Bonder C, Green F, Mullaly S, Zbytnuik L, Raharjo E, et al. Endothelium-derived Toll-like receptor 4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J Clin Invest. 2003;111(7):1011–20.CrossRefPubMedPubMedCentral
37.
go back to reference Re F, Strominger JL. Toll like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem. 2001;276(40):37692–9.CrossRefPubMed Re F, Strominger JL. Toll like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem. 2001;276(40):37692–9.CrossRefPubMed
39.
go back to reference Rabinovitch N et al. Importance of the personal endotoxin cloud in school-age children with asthma. J Allergy Clin Immunol. 2005;116:1053–7.CrossRefPubMed Rabinovitch N et al. Importance of the personal endotoxin cloud in school-age children with asthma. J Allergy Clin Immunol. 2005;116:1053–7.CrossRefPubMed
40.
go back to reference Gerhold K, Blümchen K, Bock A, Seib C, Stock P, Kallininch T, et al. Endotoxins prevent murine IgE production, th2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol. 2002;110(1):110–6.CrossRefPubMed Gerhold K, Blümchen K, Bock A, Seib C, Stock P, Kallininch T, et al. Endotoxins prevent murine IgE production, th2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol. 2002;110(1):110–6.CrossRefPubMed
41.
go back to reference Platts-Mills JA et al. Airborne endotoxin in homes with domestic animals: implications for cat-specific tolerance. J Allergy Clin Immunol. 2005;116:384–9.CrossRefPubMed Platts-Mills JA et al. Airborne endotoxin in homes with domestic animals: implications for cat-specific tolerance. J Allergy Clin Immunol. 2005;116:384–9.CrossRefPubMed
42.
go back to reference Velasco G, Campo M, Manrique O, Bellou A, He H, Arístides R, et al. Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am J Respir Cell Mol Biol. 2005;32:218–24.CrossRefPubMed Velasco G, Campo M, Manrique O, Bellou A, He H, Arístides R, et al. Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am J Respir Cell Mol Biol. 2005;32:218–24.CrossRefPubMed
43.
go back to reference Bachar O, Adner M, Uddman R, Cardell LO. Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways. Eur J Immunol. 2004;34(4):1196–207.CrossRefPubMed Bachar O, Adner M, Uddman R, Cardell LO. Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways. Eur J Immunol. 2004;34(4):1196–207.CrossRefPubMed
44.
go back to reference Sukkar MB, Xie S, Khorasani NM, Kon OM, Stanbridge R, Issa R, Chung KF. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J Allergy Clin Immunol. 2006;118(3):641–8.CrossRefPubMed Sukkar MB, Xie S, Khorasani NM, Kon OM, Stanbridge R, Issa R, Chung KF. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J Allergy Clin Immunol. 2006;118(3):641–8.CrossRefPubMed
45.
go back to reference Berin MC, Zheng Y, Domaradkzki M, Li XM, Sampson HA. Role of TLR4 in allergic sensitization to food proteins in mice. Allergy. 2006;61(1):64–71.CrossRefPubMed Berin MC, Zheng Y, Domaradkzki M, Li XM, Sampson HA. Role of TLR4 in allergic sensitization to food proteins in mice. Allergy. 2006;61(1):64–71.CrossRefPubMed
46.
go back to reference Hansel Trevor, Barnes Peter. New Drugs and targets for asthma and COPD. Progress in Respiratory Research 2010; Vol 39. Karger. Hansel Trevor, Barnes Peter. New Drugs and targets for asthma and COPD. Progress in Respiratory Research 2010; Vol 39. Karger.
Metadata
Title
Expression of toll-like receptors 2 and 4 in subjects with asthma by total serum IgE level
Authors
Astrid Crespo-Lessmann
Eder Mateus
Silvia Vidal
David Ramos-Barbón
Montserrat Torrejón
Jordi Giner
Lorena Soto
Cándido Juárez
Vicente Plaza
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2016
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-016-0355-2

Other articles of this Issue 1/2016

Respiratory Research 1/2016 Go to the issue